Market Overview
According to the MarkNtel Advisors’ research report, “Global Tissue Imaging Market Analysis, 2021”, the market is likely to grow at a CAGR of around 8.96% during 2021-26 due to factors like the increasing identification of the early detection of diseases & diagnosis and growth of chronic disease cases. Alongside that, extensive investments by businesses across the globe in the healthcare sector and advanced technologies like AI & machine learning algorithms due to their efficiency in the early detection of diseases and their treatment are other prominent factors contributing to the market growth.
Impact of COVID-19
The outbreak of the Covid-19 pandemic had the most significant impact on the market and brought extensive challenges, especially in the pharmaceutical industry globally. It is now challenging for industries to return to their optimum pace, especially in developing countries across different regions. Further, the impact of the pandemic reduced overall trade and imports, leading to a significant downfall in the market. However, with the gradual lifting of restrictions by governments, the market growth is likely to regain its pace in the forecast period.
| Report Coverage | Details |
|---|---|
| Study Period | Historical Data: 2016-19 |
| Base Year: 2020 | |
| Forecast Period: 2021-26 | |
| CAGR (2021-2026) | 8.96% |
| Regions Covered | North America: USA, Canada |
| Europe: Germany, The UK, France | |
| Asia-Pacific: China, India, Japan, South Korea, Australia and Others | |
| South America: Brazil, Mexico | |
| Middle East & Africa: UAE, Saudi Arabia, South Africa | |
| Key Companies Profiled | Abbott Laboratories, Abcam Plc, Agilent Technologies, Bio-Rad Laboratories, Fluidigm Corporation, Inc., Danaher Corporation, Olympus Corporation, Merck KGaA, F. Hoffmann-La Roche Ltd, Hamamatsu Photonics K.K., Dickinson & Company, Becton, Nikon Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc., and Shimadzu Corporation, among others. |
| Unit Denominations | USD Million/Billion |
Market Segmentation
Digital Pathology To Fuel The Market Share
Based on technology type, Digital Pathology is likely to fuel market growth in the coming years. The key factors leading to the rise include high-tech contributors with their predominant preference for synergistic activities like collaborations to sustain the enforcement globally and improve dominance. Hence, the global tissue imaging market is likely to witness substantial growth in the forecast years, reveals MarkNtel Advisors in their research report, "Global Tissue Imaging Market Analysis, 2021."
Hospitals & Diagnostic Laboratories To Possess Largest Market Share
Based on End-User Industries, Hospitals & Diagnostic Laboratories are likely to possess the largest market share in the forecast period due to the increasing cases of people with chronic diseases that need tools for tissue imaging and the integration of digital technology in tissue imaging. Moreover, a gradual shift towards better infrastructure of hospitals, operation rooms, and healthcare shall also fuel the Global Tissue Imaging Market growth in the forecast period.
Regional Landscape
Asia-Pacific Attains The Fastest Growth
Asia-Pacific region is likely to attain the fastest growth in the global tissue imaging market. Several factors contributing to the rapid rise of demand and supply requirements in the APAC region are the rising incidents of chronic diseases & contagious conditions in patients, the growing biotechnology & pharmaceutical industries, and surging activities, including R&D in imaging procedures in the APAC.
Market Driver
Although the COVID-19 pandemic led to a significant downfall of the market, however, Global Tissue Imaging Market is likely to regain its speed in the forecast period. The factors that shall boost the market growth are the growing cases of people with chronic diseases & disorders that require tissue imaging and Digital Technology. Furthermore, a shift towards value-oriented healthcare shall also fuel the Global Tissue Imaging Market growth in the forecast period.
Competitive Landscape
According to MarkNtel Advisors, the major leading players in the Global Tissue Imaging Market are Abbott Laboratories, Abcam Plc, Agilent Technologies, Bio-Rad Laboratories, Fluidigm Corporation, Inc., Danaher Corporation, Olympus Corporation, Merck KGaA, F. Hoffmann-La Roche Ltd, Hamamatsu Photonics K.K., Dickinson & Company, Becton, Nikon Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc., and Shimadzu Corporation, among others.
Key questions answered in the study
Market Outlook, Segmentation, and Statistics
Frequently Asked Questions
A. The historical data has been provided since 2016, while the base year is 2020, and the data forecast is up to 2026.
A. The measuring units of market size/industry size or the market value are USD Million and thousand units.
A. The Global Tissue Imaging Market is forecast to grow at a CAGR of 8.96% during 2021-26.
A. Abbott Laboratories, Abcam Plc, Agilent Technologies, Bio-Rad Laboratories, Fluidigm Corporation, Inc., Danaher Corporation, Olympus Corporation, Merck KGaA, F. Hoffmann-La Roche Ltd, Hamamatsu Photonics K.K., Dickinson & Company, Becton, Nikon Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc., and Shimadzu Corporation, among others are few of the leading players in the Global Tissue Imaging Market.
A. Digital Pathology is likely to attain the highest CAGR during the forecast period and maintain its significant market share.
A. Asia-Pacific continues to grow at the highest CAGR during 2021-26, thereby presenting immense opportunities to market players of the Global Tissue Imaging Market.
